Femara Letrozole and/or alternatives
Femara 2.5mgManufacturer: Novartis Source Country : Turkey
Shipped from : Mauritius
Femara 2.5mgManufacturer: Novartis Pharmaceuticals Canada Inc Source Country : Canada
Shipped from : Canada
Letrozole 2.5mgGeneric Alternative to Femara 2.5mg
Manufacturer: A UK MHRA approved Generic Manufacturer Source Country : United Kingdom
Shipped from : United Kingdom
- What is a Generic?
This item requires a prescription from your doctor
All trademarks and registered trademarks are the property of their respective owners.
Please note that the source country, shipping country and/or manufacture may vary depending on availability.
Description of Femara
Letrozole is the generic name for Femara and it is available in the form of tablets for oral administration. Letrozole is known as a nonsteroidal aromatase inhibitor and exists in the form of a white or yellow colored powder. Some of the inactive ingredients of Femara include titanium dioxide, ferric oxide, colloidal silicon dioxide, lactose monohydrate, maize starch, microcrystalline cellulose, magnesium stearate, talc, sodium starch glycolate, polyethylene glycol, and hydroxypropyl methylcellulose. You can buy Femara only if it has been prescribed and over dosing of this medication should be avoided.
Indications & Dosage of Femara
Femara is administered for treatment of breast cancer especially in postmenopausal women. Femara is also prescribed to those women who are already being administered tamoxifen for a period of 5 years. Femara works by lowering the level of estrogen in the body of postmenopausal women. This helps in slowing the growth of specific breast tumors, which rely completely on estrogen to enable their growth process in the human body.
The recommended dosage is one Femara 2.5 mg tablet, once a day with or without food and should be taken orally with a glass of water. The duration of treatment varies from one patient to another although the planned duration is for 5 years. The median duration of treatment observed currently by doctors across the world is 60 months. The dosage should be reduced by almost 50% in those patients who are suffering from severe hepatic dysfunction and cirrhosis. The recommended dosage for such patients is one Femara 2.5 mg tablet once in two days.
Side Effects & Interactions of Femara
Administration of Femara can lead to mild or moderate side effects with clearly visible symptoms. Some of the most common side effects include:
- Pain in the back, arms, or legs
- Fluid retention and swelling
- Vaginal irritation or dryness
- Weight loss or gain
- Increased sweating
- Constipation or diarrhea
- Dizziness and mild to severe headache
- Hot flushes
- Increased cough and sore throat
- Loss of appetite
- Nausea and vomiting
There are some adverse effects of administration of Femara and if you see the following symptoms then discontinue the treatment and inform your doctor.
- Rashes and hives
- Breathing difficulty
- Tightness in the chest
- One-sided weakness
- Painful urination
- Unexplained vaginal bleeding
- Anorexia and dyspepsia
- Tachycardia, angioedema, and arterial thrombosis
- Dryness of mucosa
- Stomatitis cancer pain
- Disturbances of taste
- Memory impairment
Femara is known to interact with other drugs like estradiol, aprepitant, estrone, azurette, telithromycin, levlite, mircette, norethindrone, Ovcon 50, Premarin, Progynova, Sronyx, and tacrolimus among others..
Warnings & Precautions of Femara
Femara is known to cause harm to the fetus and should not be administered to pregnant women. If you are pregnant or are planning pregnancy then it is advisable not to buy Femara without consulting with your doctor. It is known to cause congenital malformations and affects the skeletal and renal systems in newly born. It is also capable of increasing fetal toxicity. It is not known whether Femara can be secreted through human milk but it is still not recommended for breastfeeding women.
You need to discuss your medical history with the doctor prior to beginning Femara medication. You need to inform your doctor if you have the following :
- If you have kidney or liver disorders
- If you have benign ovarian stromal tumors
- If you have a history of hypersensitivity to letrozole
Femara should not be administered to patients over 70 years of age or those with weaker immune system